Pasar al contenido principal

Nanopartículas funcionales avanzadas para aplicaciones biológicas y biomédicas

RYC2020-030241-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario ASOCIACIÓN CENTRO DE INVESTIGACION COOP. BIOMATERIALES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque

  • Martínez-Parra, Lydia
  • Piñol-Cancer, Marina
  • Sanchez-Cano, Carlos
  • Miguel-Coello, Ana Beatriz
  • Di Silvio, Desiré
  • Gómez, Ana M.
  • Uriel, Clara
  • Plaza-García, S.
  • Gallego, M.
  • Pazos, Raquel
  • Groult, Hugo
  • Jeannin, Marc
  • Geraki, Kalotina
  • Fernández-Méndez, Laura
  • Urkola-Arsuaga, Ainhize
  • Sánchez-Guisado, Mª Jesús
  • Carrillo-Romero, Juliana
  • Parak, Wolfgang J.
  • Prato, Maurizio
  • Herranz, Fernando
  • Ruíz-Cabello, Jesús
  • Carregal-Romero, Susana
therosclerosis is a complex disease that can lead to life-threatening events, such as myocardial infarction and ischemic stroke. Despite the severity of this disease, diagnosing plaque vulnerability remains challenging due to the lack of effective diagnostic tools. Conventional diagnostic protocols lack specificity and fail to predict the type of atherosclerotic lesion and the risk of plaque rupture. To address this issue, technologies are emerging, such as noninvasive medical imaging of atherosclerotic plaque with customized nanotechnological solutions. Modulating the biological interactions and contrast of nanoparticles in various imaging techniques, including magnetic resonance imaging, is possible through the careful design of their physicochemical properties. However, few examples of comparative studies between nanoparticles targeting different hallmarks of atherosclerosis exist to provide information about the plaque development stage. Our work demonstrates that Gd (III)-doped amorphous calcium carbonate nanoparticles are an effective tool for these comparative studies due to their high magnetic resonance contrast and physicochemical properties. In an animal model of atherosclerosis, we compare the imaging performance of three types of nanoparticles: bare amorphous calcium carbonate and those functionalized with the ligands alendronate (for micro- calcification targeting) and trimannose (for inflammation targeting). Our study provides useful insights into ligand-mediated targeted imaging of atherosclerosis through a combination of in vivo imaging, ex vivo tissue analysis, and in vitro targeting experiments., We acknowledge M. Spuch for his scientific drawings and the Basque Government for the R&D Project in Health (grant number 2022333041). S.C.R. acknowledges the Spanish Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI) Grant PID2019-106139RA-100 funded by MCIN/AEI/10.13039/501100011033 and the Ramon y Cajal Grant RYC2020-030241-I. C.S.C. acknowledges financial support from the Spanish State Research Agency (grant PID2020-118176RJ-I100), and the Gipuzkoa Foru Aldundia (Gipuzkoa Fellows program; grant number 2019-FELL- 000018-01/62/2019). This work was performed under the Severo Ochoa Centers of Excellence Program of the Spanish State Research Agency − Grant No. CEX2018-000867-S (DIPC). SXRF analysis was carried out with the support of Diamond Light Source, beamline I18 (proposal SP27720). J.R.C. is funded by MCIN/AEI/10.13039/501100011033 (PID2021-123238OB-I00) and from La Caixa Foundation (Health Research Call 2020: HR20-00075). A.M.G. and C.U. acknowledge the Spanish Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI) Grant: PID2021-122504NB-I00 funded by MCIN/AEI/10.13039/ 501100011033 and by “ERDF A way of making Europe. W.J.P. acknowledges funding from the Cluster of Excellence “Advanced Imaging of Matter” of the Deutsche Forschungsge- meinschaft (DFG) - EXC 2056 - project ID 390715994. F.H. acknowledges MCIN (PID2019-104059RB-I00) and M.J.S.G. the Spanish Ministerio de Educación y Formación Profesional (PRE2018-083691)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NIR-II Photoresponsive magnetoliposomes for remote-controlled release and magnetic resonance imaging

  • Fernández-Méndez, Laura
  • Fernández-Afonso, Yilian
  • Martínez-Vicente, Pablo
  • Urkola-Arsuaga, Ainhize
  • Miranda-Pérez de Alejo, Claudia
  • Pisa, Irati L. de la
  • Plaza-García, Sandra
  • Ruíz-Cabello, Jesús
  • Ramos-Cabrer, Pedro
  • Gutiérrez, Lucía
  • Carregal-Romero, Susana
Magnetic nanoparticles, especially iron oxide nanoparticles, have become versatile and widely used tools in nanomedicine due to their unique magnetic properties, biocompatibility, and tunable functionality. Liposomes have further enhanced the potential of iron oxide nanoparticles by serving as effective nanocarriers with advantages such as drug coencapsulation and enhanced molecular imaging properties. In this study, we present magnetoliposomes composed of ultrasmall free-floating iron oxide nanoparticles inside liposomes (LP-IONPs) and thermoresponsive phospholipids, which were designed as dual T2-T1 magnetic resonance imaging (MRI) contrast agents for image-guided liposome degradation and infrared light-responsive nanocarriers in the second biological window for remote-controlled drug delivery. We demonstrated a dynamic shift from T2 to T1 MRI contrast during intracellular degradation of LP-IONPs, along with successful light-activated drug release in cancer cells. Biodistribution studies using MRI and histological analysis confirmed their potential for in vivo applications. These results highlight the potential of LP-IONPs as image-guided and remote-controlled drug delivery systems., S.C.R. thanks the MCIN/AEI 10.13039/501100011033 projects (PID2019-106139RA-100, CNS2023-143944, RYC2020-030241-I, and PID2022-142842OB-I00), the Ikerbasque (Basque Foundation for Science), and the Ramón Areces Foundation (CIVP21S13151). J.R.C. is funded by MCIN/AEI/10.13039/501100011033 (PID2021-123238OB-I00), the Basque Government through the Elkartek 2024 program (bmG24), and R&D projects in Health (grant number 2022333041). S.C.R. and J.R.C. thank IKERBASQUE for its support. L.G. thanks Project CNS2023-144321, funded by MICIU/AEI/10.13039/501100011033 and NextGenerationEU/PRT, and Fondo Social del Gobierno de Aragón (grupo DGA E15-23R). We also thank the Fundación contra la Hipertensión Pulmonar for funding (Empathy). CIBERES and CIBERBBN were co-funded by FEDER and ISCIII., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Iron Oxide Nanoparticles for Ligand-Mediated Targeted Imaging

  • Miranda-Pérez de Alejo, Claudia
  • Miguel-Coello, Ana B.
  • Piñol-Cancer, Marina
  • Urkola-Arsuaga, Ainhize
  • Martínez-Parra, Lydia
  • Carrillo-Romero, Juliana
  • Fernández-Méndez, Laura
  • Goñi-de-Cerio, Felipe
  • Herranz, Fernando
  • Silvio, Desire di
  • Gallego, Marta
  • Sierra-Serrano, Beatriz
  • Cardo, Lucia
  • Carregal-Romero, Susana
  • Ruiz-Cabello, Jesús
Superparamagnetic iron oxide nanoparticles (SPIONs) are widely employed as platforms for ligand-mediated targeting in multimodal imaging and targeted therapeutic applications owing to their intrinsic magnetic properties and versatility for surface and core modification. In addition to magnetic resonance imaging contrast, SPIONs can be labeled with radioisotopes incorporated into the crystalline structure or functionalized with chemically bound dyes or chelating agents, enabling complementary imaging modalities such as fluorescence imaging and positron emission tomography. However, chemical functionalization of nanoparticles with targeting ligands can induce alterations not only in their physicochemical properties but also in their interactions with biological systems. These nano-biointeractions are critical determinants of biological performance and must be carefully evaluated. In this study, we investigate the impact of ligand functionalization on SPION-cancer cell interactions to elucidate key parameters relevant to the successful clinical translation of nanomedicine-based targeted imaging agents., SCR acknowledges the Ramón Areces Foundation (CIVP21S13151),the MCIN/AEI 10.13039/501100011033 projects (PID2022-142842OB-I00,CNS2023-143944, RYC2020-030241-I), the Eusko Jaurlaritza projects(PIBA_2025_1_0057) and the Diputación Foral de Gipuzkoa (2025-CIE4-000041-01). JRC is funded by the MCIN/AEI/10.13039/501100011033(PID2021-123238OB-I00 and PID2024-155807OB-C21), the Eusko Jaurlar-itza under the Elkartek 2024 and 2025 Programs (KK-2024-00041, bmG24,and KK-20205-00084, TERACARD, respectively), and R&D projects in Health (Grant number 2022333041). SCR and JRC thank IKERBASQUE for their sponsorships. We also acknowledge the “Fundación contra la hipertensión pulmonar” for funding (Empathy)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

NIR-II Photoresponsive Magnetoliposomes for Remote-Controlled Release and Magnetic Resonance Imaging

  • Fernández-Méndez, Laura
  • Fernández-Afonso, Yilian
  • Martínez-Vicente, Pablo
  • Urkola-Arsuaga, Ainhize
  • Miranda-Pérez de Alejo, Claudia
  • L. de la Pisa, Irati
  • Plaza-García, Sandra
  • Ruíz-Cabello, Jesús
  • Ramos-Cabrer, Pedro
  • Gutiérrez, Lucía
  • Carregal-Romero, Susana
Magnetic nanoparticles, especially iron oxide nano-particles, have become versatile and widely used tools in nanomedicinedue to their unique magnetic properties, biocompatibility, and tunablefunctionality. Liposomes have further enhanced the potential of ironoxide nanoparticles by serving as effective nanocarriers with advantagessuch as drug coencapsulation and enhanced molecular imagingproperties. In this study, we present magnetoliposomes composed ofultrasmall free-floating iron oxide nanoparticles inside liposomes (LP-IONPs) and thermoresponsive phospholipids, which were designed asdual T2-T1 magnetic resonance imaging (MRI) contrast agents forimage-guided liposome degradation and infrared light-responsivenanocarriers in the second biological window for remote-controlleddrug delivery. We demonstrated a dynamic shift from T2 to T1 MRIcontrast during intracellular degradation of LP-IONPs, along with successful light-activated drug release in cancer cells.Biodistribution studies using MRI and histological analysis confirmed their potential for in vivo applications. These results highlightthe potential of LP-IONPs as image-guided and remote-controlled drug delivery systems.